Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma
The American Journal of Surgery Sep 02, 2017
Arima K, et al. – Researchers aimed at determining the usefulness of the postoperative C–reactive protein/albumin (CRP/Alb) ratio in patients with pancreatic ductal adenocarcinoma (PDAC). The CRP/Alb ratio at POD14 was established as a useful predictive marker of surgical invasion, biological reaction, and prognosis in PDAC patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
